MRI around the time of diagnostic biopsy may identify patients at increased risk for early reclassification during prostate cancer active surveillance.

Researchers from universities including Harvard and the University of California met with participants from multiple fields, ...

Prostate cancer is the most common solid organ cancer in American men and the second leading cause of cancer-related death ...

While they were both approved several years back to treat the same two types of prostate cancer, Astellas and Pfizer’s Xtandi ...

Know about Prostate cancer as it has significant impact on men's health. Here are the details about this disease.

Research shows 69 per cent of Black adults are unaware that Black men face a two-fold increased risk of developing prostate ...

In a landmark study, Johnson & Johnson has announced that ERLEADA (apalutamide) significantly reduces the risk of death by 23 ...

Experts warn that frequent trips to the bathroom at night could signal serious health issues, urging individuals to pay ...

The Man Van will be returning to Medicine Hat this weekend, offering a change for residents to get their blood checked and screen for potentially life-threatening cancer. The van is put on by Rocky ...

A broad coalition of health experts, policymakers, development partners, and civil society organizations convened at the ...

Prostate cancer is the most commonly diagnosed cancer in males in 118 of 185 countries, but it's the leading cause of death ...

Sep. 3, 2024 — Compounds containing astatine-211 (211At) can be used in targeted radiotherapies for prostate cancer, but deastatination in the body remains a significant hurdle. Now, researchers ...